Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
We do not claim affiliation with or endorsement by Novo Nordisk.
If your request is denied, you have the right to appeal
The segment is impelled by the broad use and proven efficacy of various injectable formulations, including dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy), and liraglutide (Victoza, Saxenda) in managing type 2 diabetes and obesity
Kidney problems : May lead to dehydration and worsen kidney function in patients with pre-existing kidney conditions
Cardiovascular benefits: Numerous studies have demonstrated that GLP-1s reduce cardiovascular risk in patients with diabetes or those at high cardiovascular risk, independent of their HbA1c levels
